Concord Biotech Limited

NSE BSE

Performance

Today's Low		Today's High
2,031.05 2,005.70		2,145.00 2145.00

52 Week Low		52 Week High
1,259.45 (29-Nov-2023) 1,277.75 (21-Dec-2023)		2,664.00 (20-Sep-2024) 2,658.00 (20-Sep-2024)

Open: 2,040.00 2,005.70

Previous Close: 2,033.70 2,036.50

Volume: 0.91

Total Traded value: 19.08 (₹ Lakhs)

Upper circuit: 2,440.40 1,762.10

Lower circuit: 1,627.00 1,174.80

Market Depth

Buy Order Quantity		Sell Order Quantity
641		1

Bid Price	Quantity
2,127.50	641.00
0.00	0.00
0.00	0.00
0.00	0.00
0.00	0.00
Total:	641

Ask Price	Quantity
0.00	0.00
0.00	0.00
0.00	0.00
0.00	0.00
0.00	0.00
Total:	1,065

Fundamentals

Market Cap:	₹223.88 Cr
PE Ratio (TTM):	67.95
PB Ratio:	14.04
Industry P/E:	64.73
Debt to Equity:	-

ROE:	20.67
EPS (TTM):	31.42
Book Value:	0.00
Face Value:	1.00

Financials

	Jun, 2023	Sep, 2023	Sep, 2023	Jun, 2023	Jun, 2023
Revenue	278.17 Cr	2.05 Cr	84.06 Cr	82.91 Cr	194.83 Cr
Profit	16.44 Cr	3.53 Cr	11.56 Cr	11.07 Cr	48.47 Cr
Expense	257.18 Cr	1.91 Cr	69.00 Cr	69.36 Cr	136.47 Cr
Comprehensive income	16.34 Cr	3.53 Cr	11.56 Cr	11.07 Cr	48.39 Cr
EPS	1.88	11.17	0.94	0.97	4.63

Concord Biotech Limited, a biopharmaceutical company, is involved in various aspects of the pharmaceutical industry, including research and development, manufacturing, marketing, and sales of pharmaceutical products. The company operates both in India and internationally. Its main focus is on fermentation-based active pharmaceutical ingredients, particularly in the areas of immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic fields.

Concord Biotech Limited offers a range of products within these therapeutic segments, such as tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, and pimecrolimus for immunosuppressants; temsirolimus, everolimus, romidepsin, mitomycin, midostaurin, and dactinomycin for oncology; mupirocin, mupirocin calcium, vancomycin hydrochloride, and teicoplanin for anti-bacterial applications; anidulafungin, caspofungi, and micafungin sodium for anti-fungal treatments; and lovastatin and pravastatin sodium for other applications.

Furthermore, Concord Biotech Limited also provides contract research and manufacturing services in the fields of fermentation and semi-synthesis products. The company has been in operation since 1984 and is headquartered in Ahmedabad, India.

Company name	Listing date	Industry	NSE symbol BSE symbol
Concord Biotech Limited	Aug, 2023 Aug, 2023	Pharmaceuticals Pharmaceuticals	CONCORDBIO CONCORDBIO

Shareholding pattern

Sep, 2023

Promoters

44.08%
Public

55.92%
Shares held by Employee Trusts

0.00%

Promoters
	44.08%

Public
	55.92%

Shares held by Employee Trusts
	0.00%

Concord Biotech Limited FAQ's

What is the range of today's stock performance for Concord Biotech Limited?

Today's stock performance witnessed a fluctuation from a minimum of 2,031.05 on the NSE (National Stock Exchange) to a maximum of 2,145.00. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 2,005.70 to a high of 2,145.00.

What are the 52-week low and high values for Concord Biotech Limited?

The stock's performance over the past 52 weeks reveals a low of 1,259.45 (occurred on 29-Nov-2023) and a high of 2,664.00 (achieved on 20-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 1,277.75 (on 21-Dec-2023), and the 52-week high is 2,658.00 (on 20-Sep-2024).

What was the opening and previous closing prices for Concord Biotech Limited?

The stock's performance over the past 52 weeks reveals a low of 1,259.45 (occurred on 29-Nov-2023) and a high of 2,664.00 (achieved on 20-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 1,277.75 (on 21-Dec-2023), and the 52-week high is 2,658.00 (on 20-Sep-2024).

What is the total volume and traded value for Concord Biotech Limited for the day?

The total volume is 1, and the total traded value is 19.08 (₹ Lakhs).

What are the upper and lower circuit limits for Concord Biotech Limited?

The upper circuit limit is 2,440.40, and the lower circuit limit is 1,627.00.

What is the market cap and PE ratio for Concord Biotech Limited?

The market cap is ₹223.88 Cr, and the PE ratio (TTM) is 64.73.

What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Concord Biotech Limited?

ROE is 20.67, EPS is 31.42, book value is not available

What are the revenue and profit figures for the latest quarter and previous quarters for Concord Biotech Limited?

In Jun 2023, Revenue is ₹2781700000.00, and Profit is ₹164368000.00. In Sep 2023, Revenue is ₹20472000.00, and Profit is ₹35291000.00.

When was Concord Biotech Limited listed, and what industry does it belong to?

The company, Concord Biotech Limited, was listed in Aug 2023 and belongs to the Pharmaceuticals industry. Its NSE symbol is CONCORDBIO.

What is the current shareholding pattern of the Concord Biotech Limited?

As of latest available update, promoters hold 44.08%, the public holds 55.92%, and Employee Trusts holds 0.00.

Search

Navigation section